Skip to main content
Clinical Trials/DRKS00024663
DRKS00024663
Recruiting
未知

Virtual reality-based meditation for enhancement of wellbeing, quality of life and patient satisfaction for in-patients undergoing chemotherapy

niversitätsklinikum Augsburg0 sites40 target enrollmentFebruary 26, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
C34
Sponsor
niversitätsklinikum Augsburg
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 26, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Augsburg

Eligibility Criteria

Inclusion Criteria

  • Adult patients capable of consent who are receiving inpatient chemotherapy for lung cancer or acute myeloid or acute lymphatic leukemia.

Exclusion Criteria

  • Non\-consenting patients; minor patients; pregnant patients; patients admitted as emergencies; patients participating in another intervention study that may have a potential impact on the endpoints of this study; Patients with infectious disease and need for isolation, pre\-existing dementia, schizophrenia, hallucinations, panic attacks, or epileptic seizures; pacemaker or defibrillator wearers; patients taking neuroleptics or antiepileptic drugs; patients with active alcohol and/or drug abuse; lack of proficiency in German or English.

Outcomes

Primary Outcomes

Not specified

Similar Trials